Pure Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.89M | Buy |
7,972
+1,815
| +29% | +$621K | 0.04% | 149 |
|
|
2026
Q1 | $2.17M | Buy |
6,157
+648
| +12% | +$231K | 0.03% | 158 |
|
|
2025
Q4 | $1.8M | Buy |
5,509
+998
| +22% | +$317K | 0.03% | 172 |
|
|
2025
Q3 | $1.27M | Sell |
4,511
-311
| -6% | -$90.2K | 0.02% | 186 |
|
|
2025
Q2 | $1.35M | Buy |
4,822
+652
| +16% | +$185K | 0.02% | 178 |
|
|
2025
Q1 | $1.3M | Buy |
4,170
+667
| +19% | +$197K | 0.03% | 156 |
|
|
2024
Q4 | $913K | Buy |
3,503
+142
| +4% | +$42.1K | 0.02% | 167 |
|
|
2024
Q3 | $1.08M | Sell |
3,361
-25
| -0.7% | -$8.18K | 0.03% | 151 |
|
|
2024
Q2 | $1.06M | Buy |
3,386
+544
| +19% | +$160K | 0.03% | 144 |
|
|
2024
Q1 | $808K | Buy |
2,842
+245
| +9% | +$71.7K | 0.03% | 157 |
|
|
2023
Q4 | $748K | Buy |
2,597
+106
| +4% | +$28.9K | 0.03% | 159 |
|
|
2023
Q3 | $669K | Buy |
2,491
+442
| +22% | +$110K | 0.03% | 150 |
|
|
2023
Q2 | $455K | Buy |
2,049
+22
| +1% | +$5.11K | 0.02% | 171 |
|
|
2023
Q1 | $490K | Buy |
2,027
+74
| +4% | +$18.2K | 0.02% | 166 |
|
|
2022
Q4 | $513K | Buy |
1,953
+63
| +3% | +$16.9K | 0.03% | 155 |
|
|
2022
Q3 | $426K | Buy |
1,890
+50
| +3% | +$12.1K | 0.02% | 157 |
|
|
2022
Q2 | $448K | Buy |
1,840
+210
| +13% | +$51.5K | 0.03% | 166 |
|
|
2022
Q1 | $394K | Sell |
1,630
-231
| -12% | -$53.1K | 0.02% | 162 |
|
|
2021
Q4 | $419K | Buy |
1,861
+130
| +8% | +$27.4K | 0.02% | 144 |
|
|
2021
Q3 | $368K | Buy |
1,731
+12
| +0.7% | +$2.76K | 0.03% | 141 |
|
|
2021
Q2 | $419K | Buy |
1,719
+13
| +0.8% | +$3.2K | 0.03% | 133 |
|
|
2021
Q1 | $424K | Buy |
1,706
+237
| +16% | +$56.5K | 0.04% | 128 |
|
|
2020
Q4 | $338K | Hold |
1,469
| – | – | 0.04% | 134 |
|
|
2020
Q3 | $373K | Hold |
1,469
| – | – | 0.05% | 112 |
|
|
2020
Q2 | $346K | Buy |
1,469
+40
| +3% | +$9.13K | 0.05% | 104 |
|
|
2020
Q1 | $290K | Buy |
1,429
+200
| +16% | +$43.7K | 0.05% | 108 |
|
|
2019
Q4 | $296K | Hold |
1,229
| – | – | 0.05% | 119 |
|
|
2019
Q3 | $238K | Sell |
1,229
-87
| -7% | -$16.7K | 0.04% | 120 |
|
|
2019
Q2 | $243K | Sell |
1,316
-253
| -16% | -$45.3K | 0.04% | 123 |
|
|
2019
Q1 | $298K | Buy |
1,569
+137
| +10% | +$26.2K | 0.06% | 117 |
|
|
2018
Q4 | $279K | Buy |
1,432
+116
| +9% | +$22.6K | 0.06% | 118 |
|
|
2018
Q3 | $273K | Buy |
+1,316
| New | +$259K | 0.06% | 120 |
|
Other funds holding AMGN
Pure Financial Advisors's AMGN Position: Q2 2026 in Review
Pure Financial Advisors increased its Amgen (AMGN) stake by 29% in Q2 2026, buying an estimated $621K and bringing the position to 7,972 shares worth $2.89M. The position accounts for 0.04% of the portfolio, ranked #149.
Pure Financial Advisors first reported a position in AMGN in Q3 2018 and has held it in 32 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Pure Financial Advisors held 7,972 shares of Amgen worth $2.89M as of Q2 2026.
- Pure Financial Advisors bought 1,815 Amgen shares in Q2 2026, an estimated $621K.
- Amgen made up 0.04% of Pure Financial Advisors's portfolio in Q2 2026, its #149 holding.
- Pure Financial Advisors first reported a position in Amgen in Q3 2018 and has held it in 32 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.